health
‘The Future of Health and Medicine Is Coming Faster Than You Think’—From Israeli Labs to Global Health Systems
A delegation of US and international health leaders visited Israeli research institutions and startups to examine how scientific discovery is translated into scalable medical technologies
By...
Read More
Lilly’s Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
Feb 18 (Reuters) – Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed better results in patients with the skin disease and obesity in a late-stage study, compared to Taltz alone.
The drugs showed greater improvement in...
Read More
Olympic figure skaters offer wellness tips for weekend athletes. The ‘hard ice always wins’
The figure skaters at the Winter Olympics make it look easy; sheer elegance on hard ice.
But elite skaters also fight injuries, much like the rest of us who work out, go to the gym or swim to stay fit.
“No athlete at this level is 100% fully healthy,” Gretchen Mohney, the...
Read More
health Headlines
A long-acting HIV drug arrives in Zimbabwe for some at highest risk- NYC nursing walkout ends as last striking nurses approve new contract
- Social media can be addictive even for adults, but there are ways to cut back
- Trump administration to stand by tough Biden-era mandates to replace lead pipes
- Cuba’s health care system pushed to the brink by US fuel blockade, Cuban minister says
- US FDA approves Vanda’s antipsychotic pill, shares climb
- US sugar industry weighs impact from new dietary guidelines regulation
- Trump administration eases limits on coal plants for emitting mercury, other toxins
- Measles cases in South Carolina rise by 11 to 973
- Nurses in New York reach tentative deal to end six-week strike
- MAHA activists warn Trump could lose their support over glyphosate order
- What is ALS, the disease that killed actor Eric Dane?
- Mississippi hospital system closes all clinics after ransomware attack
- Sonova expects FY revenue at lower end of target range, CEO says in interview
- Nearly 3.4 million pounds of recalled Trader Joe’s chicken fried rice products may contain glass
- Nurses and New York hospital system reach a tentative deal to end the city’s largest nursing strike
- Grail shares plummet after UK study raises doubts over cancer test’s prospects
- Spain’s top court rejects father’s bid to halt daughter’s euthanasia
- Novo Nordisk nominates two drug industry veterans to strengthen board
- Health Rounds: Link between low oxygen and reduced blood sugar could yield new diabetes treatments
- Trump EPA to weaken rule limiting harmful mercury, air toxins from coal plants
- France lifts most cattle movement curbs on eve of Paris farm show
- Indian drugmaker Sai Life Sciences to boost headcount by about 20% amid global demand upswing
- Trump climate health rollback likely to hit poor, minority areas hardest, experts say
- Novartis to exit India unit in $159 million deal; Mumbai-listed shares surge 20%
- Texas sues Sanofi for allegedly ‘bribing’ providers to boost drug prescriptions
- Australia’s Ramsay Health to spin off Ramsay Sante stake after year‑long review, shares rise
- Amazon can be sued over suicides linked to sodium nitrite, Washington Supreme Court rules
- Walgreens cuts workforce after private equity buyout, Bloomberg News reports
- Johnson & Johnson explores $20 billion sale of orthopedics unit, source says
- US CDC cancels February vaccine adviser meeting; no new one set yet
- BioNTech sues Moderna for patent infringement over COVID shots
- Wisconsin passes expanded Medicaid for moms, would leave Arkansas as only state without it
- Cassava Sciences says US DOJ has closed investigation into company
- EU says cereulide exposure risk low after baby formula recalls
- Zimbabwe rolls out new HIV prevention drug lenacapavir
- Hims & Hers Health to acquire Australia’s Eucalyptus for up to $1.15 billion
- Analysis-Hims & Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders
- Bayer: glyphosate shortages not expected outside the US after executive order
- Japanese government panel endorses Sumitomo Pharma’s iPS-derived treatment for Parkinson’s
- Explainer-Will Bayer’s proposed $7.25 billion Roundup deal bring legal closure?
- Early prenatal care, considered best for moms and babies, is on the decline in the US
- Afghanistan faces catastrophic hunger crisis as aid cuts force the WFP to turn away 3 in 4 children
- NIH’s Bhattacharya will also run the CDC while Trump administration looks for a permanent director
- Italian toddler deemed too sick for second transplant, doctors say
- US NIH director Bhattacharya to temporarily run CDC
- Cereulide found in two baby formula products recalled by Danone, Switzerland says
- Guinea-Bissau stops vaccine study funded by Trump administration
- Millions of US Medicare Advantage enrollees forced to switch plans, study finds
- Moderna says the FDA will consider its new flu shot after resolving a public dispute
